DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio

Wednesday, 29 April 2015

From L to R: Amanda Fontes and Kelsey Papineau, Indigenous Science Student Representatives. Photo by: Mike Latschislaw.

Indigenous science students are making a difference

March 17, 2015 — As Indigenous Student Representatives of the Science Students Association, Amanda Fontes and Kelsey Papineau are passionate about finding opportunities to develop an inclusive and supportive learning environment that promotes Indigenous student success, and enhances the university experience of Indigenous students like themselves.

Image result for manitoba.

Tuesday, 21 April 2015

Dr. Emily Peterson

Emily Peterson, Ph.D., Amgen scientist and green chemistry team lead, applies green chemistry principles in her lab at Amgen's Cambridge Research facility.

  Genetic Engineering & Biotechnology News

read at http://www.genengnews.com/gen-articles/green-chemistry-initiatives-take-shape/3906/  

 links http://www.researchgate.net/profile/Emily_Peterson http://www.pubfacts.com/author/Emily+Peterson
  • Department of Medicinal Chemistry
    United States



Medicinal Chemist with experience working in Oncology and Neuroscience. Leader of Green Chemistry team at the Amgen, Cambridge facility. Our effort is currently focused on incorporating the principles of Green Chemistry into drug discovery research. Specialties:Structure-based drug design, alkaloid synthesis
Emily Peterson


 Emily Peterson


Senior Scientist

March 2012 – Present (3 years plus) Cambridge, MA
Involved in lead optimization efforts (compound design and synthesis) on an ion channel project, overseeing external chemistry resources for the project. Chemistry lead for early-stage neuroscience project. Manager of one M.S. chemist and two Ph.D. contract workers at Amgen. Green Chemistry team leader for Medicinal Chemistry at Amgen, achieved reduction of dichloromethane usage at the site by over 60%. I represent Amgen Medicinal Chemistry on the ACS Green Chemistry Institute Pharmaceutical Round Table.
Map of cambridge ma


August 2007 – March 2012 (4 years 8 months)Cambridge, MA
Responsible for the design and synthesis of compounds for oncology and neuroscience projects in both the lead optimization and lead identification stages. Managed 1 B.S./M.S. chemist and a team of CRO chemists. Initiated and led the Drug Discovery Green Chemistry Team at the Amgen Massachusetts site. Involved in the interviewing and hiring of both Ph. D. and B.S./M.S. scientists.

Postdoctoral Fellow

Harvard University - Jacobsen Group
July 2005 – July 2007 (2 years 1 month)
Developed a method for the asymmetric addition of indoles to cyclic N-acyl iminium ions


Preparation of dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors

Europe WO 2013122897 A1 20130822
Filed August 22, 2013

Preparation of bicyclic aryl and heteroaryl sodium channel inhibitors

Europe WO 2013086229 A1
Filed June 13, 2013

Preparation of heteroaryl compounds as PIKK inhibitors for the treatment of cancer

Europe WO 2010132598
Issued November 18, 2010
zimidazole compounds as mTOR kinase inhibitors for the treatment of cancer

Europe WO 2010096314
Issued August 26, 2010

Fused heterocyclic derivatives as HGF modulators and their preparation and methods of use

Europe WO 2009091374
Issued July 23, 2009

Benzoimidazole derivatives as PI3 kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cancers

United States US 20090163489
Issued June 25, 2009


Sustainable Chromatography (an oxymoron?)(Link)

Green Chemistry
July 15, 2014
Chromatography is routinely used in drug discovery as a means to isolate intermediates and final compounds. From a sustainability perspective, it is one of the largest contributors of solvent waste in the drug discovery process. The medicinal chemistry subgroup within the American Chemical Society's Green Chemistry Institute Pharmaceutical Roundtable (ACS GCI PR) offers a perspective aimed at...more

Sustainable Practices in Medicinal Chemistry: Current State and Future Directions.(Link)

Journal of Medicinal Chemistry
April 2013
The medicinal chemistry subgroup of the American Chemical Society’s Green Chemistry Institute Pharmaceutical Roundtable (ACS GCI PR) offers a perspective on the current state of environmentally sustainable practices in medicinal chemistry with the aim of sharing best practices more widely and highlighting some potential future developments.

Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitors.(Link)

Bioorganic & medicinal chemistry letters
August 1, 2012
mTOR is a critical regulator of cellular signaling downstream of multiple growth factors. The mTOR/PI3K/AKT pathway is frequently mutated in human cancers and is thus an important oncology target. Herein we report the evolution of our program to discover ATP-competitive mTOR inhibitors that demonstrate improved pharmacokinetic properties and selectivity compared to our previous leads. Through...more

A convenient guide to help select replacement solvent for dichloromethane in chromatography(Link)

Green Chemistry
August 20, 2012
One of the largest contributors to chlorinated solvent waste in medicinal chemistry is chromatography. A set of “drug-like” compounds was employed to compare the relative eluting strengths of greener solvent systems. Disclosed herein is an experimentally-derived solvent selection guide to aid chemists in choosing greener solvents for chromatographic purification, with a particular focus on...more

Discovery of triazine-benzimidazoles as selective inhibitors of mTOR.(Link)

Bioorganic Medicinal Chemistry Letters
February 12, 2011
mTOR is part of the PI3K/AKT pathway and is a central regulator of cell growth and survival. Since many cancers display mutations linked to the mTOR signaling pathway, mTOR has emerged as an important target for oncology therapy. Herein, we report the discovery of triazine benzimidazole inhibitors that inhibit mTOR kinase activity with up to 200-fold selectivity over the structurally homologous...more

Facile preparation of protected benzylic and heteroarylmethyl amines via room temperature Curtius rearrangement(Link)

Tetrahedron Letters
May 26, 2010
A step-wise, room temperature procedure for acyl azide formation and the subsequent Curtius rearrangement of phenyl and heteroaryl acetic acids is described. We have developed a protocol for room temperature Curtius rearrangement in MeOH or CHCl3 that provides an improvement over standard conditions, avoiding the use of additives or heat. This room temperature optimization of the Curtius...more

Enantioselective, thiourea-catalyzed intermolecular addition of indoles to cyclic N-acyl iminium ions.(Link)

Angewandte Chemie International Edition
July 16, 2009
N-acyl iminium ion intermediates underwent intermolecular addition by these nucleophiles under the catalysis of a chiral thiourea Schiff base derivative. A variety of functionalized indole frameworks were assembled with high enantioselectivity from simple precursors by this method

Enantioselective Pictet−Spengler-Type Cyclizations of Hydroxylactams:  H-Bond Donor Catalysis by Anion Binding(Link)

Journal of the American Chemical Society
October 17, 2007
Highly enantioenriched indolizinone and quinolizinone products are obtained in the thiourea-catalyzed cyclization of tryptamine-derived hydroxylactams. Substituent and counterion effect studies point to a novel mechanism of catalysis involving rate-limiting anion abstraction and binding by the thiourea.

Synthesis of all low-energy stereoisomers of the tris(pyrrolidinoindoline) alkaloid hodgkinsine and preliminary assessment of their antinociceptive activity.(Link)

The Journal of Organic Chemistry
September 21, 2007
The previously unknown stereoisomers 3, 4, ent-1, and ent-4 of the tris(pyrrolidinoindoline) alkaloids hodgkinsine (1) and hodgkinsine B (2) were prepared by stereocontrolled total synthesis. In each synthesis, a catalyst-controlled intramolecular Heck reaction was the key step in appending a third cis-pyrrolidinoindoline ring to a hexacyclic chimonanthine precursor. Results of the preliminary...more

Synthesis of Dihydroquinolinones Angularly-Fused to Tetrahydrobenzazepinone Rings

January 2006

Contiguous stereogenic quaternary carbons: a daunting challenge in natural products synthesis.(Link)

Proceedings of the National Academy of Sciences
August 17, 2004
One element of structure that invariably increases the difficulty of a chemical synthesis is the presence in the target molecule of contiguous all-carbon quaternary stereocenters. This Perspective will examine the most useful transformations and strategies devised recently for directly assembling this structural unit.

Synthesis of aromatic bisabolene natural products via palladium-catalyzed cross-couplings of organozinc reagents.(Link)

Journal of Organic Chemistry
May 2004
Aromatic bisabolene derivatives were prepared by two methods involving cross-coupling of organozinc reagents. The first synthesis of (±)-glandulone A (10), as well as syntheses of (±)-curcuhydroquinone (8) and (±)-curcuquinone (9), were accomplished via coupling of a secondary alkyl zinc reagent (1,5-dimethyl-4-hexenylzinc halide, 18) to protected bromohydroquinones using Pd(dppf)Cl2 as catalyst....more

Enantioselective synthesis of (−)-idiospermuline(Link)

August 25, 2003
The enantioselective total synthesis of the nonacyclic polypyrrolidinoindoline (−)-idiospermuline is described. Stereocontrolled formation of the vicinal quaternary carbon centers is achieved in a single step by dialkylation of an unsymmetrical prostereogenic dienolate with a tartrate-derived chiral dielectrophile. A catalyst-controlled diastereoselective Heck cyclization is employed to form the...more

Enantioselective total synthesis of the cyclotryptamine alkaloid idiospermuline.(Link)

Angewandte Chemie International Edition
June 5, 2003
Stereogenic quaternary carbons present the primary challenge in the syntheses of trispyrrolidinoindoline alkaloids such as idiospermuline. In its synthesis the two contiguous quaternary centers are expediently addressed by combining the lithium dienolate of a differentially protected dihydroisoindigo with a tartrate-derived electrophile. The third quaternary stereocenter is introduced by a...more

An expedient total synthesis of (±)-caparratriene(Link)

Tetrahedron Letters
July 2, 1999
(±)-Caparratriene has been synthesized by two succinct routes. The first relies on two Wittig reactions and produces (±)-caparratriene and its 2Z isomer as an inseparable 2:1 mixture. The second more efficient synthesis produces only the naturally occurring 2E isomer and proceeds in 36% overall yield. The key step in this short synthesis is the Suzuki coupling of E-2-bromo-2-butene with the E-...more

Brindar Sandhu

Brindar Sandhu at the UCB Amgen Scholars Poster Session ...


Brindar Sandhu

Email: brindar.sandhu@emory.edu https://www.linkedin.com/pub/brindar-sandhu/29/a79/a42 http://www.researchgate.net/profile/Brindar_Sandhu


University of Michigan

B.S.E., Biomedical Engineering
2006 – 2010
Activities and Societies: Asha for Education, SWE, BMES


Graduate Student

Emory University
August 2011 – Present (3 years 9 months)Atlanta, GA
Genetics & Molecular Biology Ph.D. program
Dissertation topic: "Aminoglycoside phosphotransferases: Models for Enzyme Evolution" Rotation project, lab of Justin Gallivan, Ph.D.: "Creating a Theophylline-binding OFF-Riboswitch" Attempted to create a riboswitch utilizing an aptamer that changed secondary structure upon binding of the small molecule theophylline in the 5’ UTR, such that downstream translation of a reporter gene is inhibited Rotation project, lab of David Lynn, Ph.D.: "Selecting for Amyloid Production to Epigenetically Regulate Plasmid Copy Number" Developed a proposal based on the RepA plasmid replication protein, specifically a mutant version that induces the formation of amyloid, to regulate plasmid copy number through antibiotic selection and amyloid production Rotation project, lab of Ichiro Matsumura, Ph.D.: "Using Bacteria as a Sensor" Attempted to engineer the metal-reducing bacterium, Shewanella oneidensis, to act as a gating detection device to, upon addition of lactose, sense the small molecule, theophylline, and upon binding, transcribe and translate the lacY and lacZ genes and emit electrons that can be detected using a voltmeter

Social co-chair, Graduate Student Council

Emory University
August 2013 – Present (1 year 9 months)
Help plan, set-up, and execute mixers for Laney graduate students (4 per year) Facilitate cab reimbursement program with the Graduate Student Government Association (GSGA) Serve as a Laney representative to GSGA

President, Graduate Students in Genetics

Emory University
November 2013 – August 2014 (10 months)
Co-founded and currently aid in running the extracurricular group Graduate Students in Genetics, or GSIG. We hold monthly networking mixers in order to facilitate networking for those interested in genetics within the graduate school. GSIG is a chartered group through the Laney Graduate School's Graduate Student Council.

GMB Student Representative

Emory University
August 2013 – July 2014 (1 year)
Function as a liaison between faculty and students within the GMB program Serve on the recruitment and the retreat committee to help plan, set up, and run recruitment for incoming class as well as the annual program retreat

Teaching Assistant - BIOL 264: Genetics: A Human Perspective

Emory University
January 2014 – May 2014 (5 months)
Facilitate weekly class discussions
Graded three exams per semester along with another TA and the instructor.

Teaching Assistant - BIOL 370: Introduction to Microbiology

Emory University
August 2012 – December 2012 (5 months)Atlanta, GA
Graded weekly homework assignments and three exams throughout the semester for an undergraduate course of 130 students
Held review sessions in preparation for the three exams Held weekly office hours for assistance with homework assignments

Postbaccalaureate Research Fellow

National Institutes of Health
June 2010 – June 2011 (1 year 1 month)Bethesda, MD
National Institute of Diabetes and Digestive and Kidney Diseases Genetics of Simple Eukaryotes Section Laboratory of Biochemistry and Genetics
Ran a screen for URE2 mutations that prevent the Hsp40 Ydj1 from curing Ure2delta yeast cells of the [URE3] prion to deduce essential domain interactions for prion propagation in Saccharomyces cerevisiae Tested known mutations to the Hsp40 Sis1 that cause changes to the [PSI+] prion for phenotypic changes to the [URE3] prion in Saccharomyces cerevisiae

Grader, BiomedE 321: Bioreaction Engineering & Design

University of Michigan
January 2010 – April 2010 (4 months)Ann Arbor, MI
Department of Biomedical Engineering
Worked with the instructional aide, graduate student instructor, and the professors to grade homework assignments, exams, and regrade requests, return them to the students, and upload grades online

Undergraduate Research Assistant

University of Michigan Health System
May 2008 – April 2010 (2 years)Ann Arbor, MI
Urology Department
Project 1 (Sept 2009 – Apr 2010): “The Roles of Soluble E-Cadherin and EGFR in Prostate Cancer” Used timed experiments, immunoprecipitations, and western blots to analyze interaction of soluble E-Cadherin and EGFR in prostate cancer cell lines Project 2 (Jun 2008 – Apr 2009): “The Role of ADAM15 in the Metastatic Progression of Prostate Cancer” Examined the interaction of ADAM15 (A Disintegrin And Metalloproteinase) and EGFR family members and the AKT signaling pathway in LNCaP cells using western blots and immunoflourescence Presented results in oral presentation at conclusion of program Wrote final reports at the end of each semester summarizing data and conclusions Co-author on abstract submitted to American Association of Cancer Research: Advances in Prostate Cancer Research National Conference: “Activation of the Disintegrin Protease ADAM15 Leads to Cleavage of E-cadherin and Enhanced Signaling in Prostate Cancer Cells”

Amgen Scholar

University of California, Berkeley
June 2009 – August 2009 (3 months)Berkeley, CA
Department of Bioengineering
Project: “Induced Control of MLCK-Dependent Mechanobiology in Human Glioma Cells” Performed 2-D collagen gel, 3-D gel contraction, immunoflourescence and cell migration assays to demonstrate changes in tumor invasiveness properties in human glioma cells as myosin light chain kinase (MLCK) activity was varied using a tetracycline-off promoter construct Presented results in poster and oral presentations at conclusion of program Discussed research with other scholars and professional scientists at 2009 Amgen Scholars U.S. Symposium at UCLA (July 2009)

Summer Research Intern

University of Kansas
May 2007 – July 2007 (3 months)Lawrence, KS
Research Experience for Undergraduates Department of Chemical and Petroleum Engineering
Project: “Subcritical CO2-melded Poly(D,L-lactide-co-glycolide) Microsphere-based Tissue Scaffolds for Cartilage Tissue Engineering” Seeded novel tissue scaffolds with chondrocyte cells to determine feasibility for future osteochondral tissue engineering Tested strength of microsphere-based scaffolds with uniaxial compression tests Tested cell viability and cartilage formation with histological and immunohistochemical assays Presented results in the form of a poster at a university-wide poster symposium

Honors & Awards

NIH GMB Training Grant

Emory Genetics & Molecular Biology Ph.D. Program
August 2011


Emory University

  • Introduction to prokaryotic molecular genetics
  • Genetics of progenitor and stem cells
  • Eukaryotic chromosome organization & function
  • Model genetic systems
  • Ethical conduct in research
  • Hypothesis design & scientific writing
  • Introductory graduate seminar

Limin Wang, Milind Singh, Mihael Lazebnik, Michael Detamore, and Liang Zhao. Front Row: Ivy Tran, Brindar Sandhu, Jeannie Salash, and Jordan Christian.

Thursday, 16 April 2015

Myself recovering from leg swelling

DR ANTHONY CRASTO at Metro hospital Manpada Thane, India
13-16 Apr,  2015
I  am back

Dr. Akanksha Gupta

Dr.Akanksha Gupta

Dr. Akanksha Gupta

Medicinal Chemist with industrial and Post doc experience

aks25gupta (Google Talk)

A professional and progressive researcher through continuous learning and implementing new ideas through my dedication, hard work. Skilled researcher with doctorate in medicinal and organic chemistry. Strong background in data interpretation by modern spectroscopic methods, drug designing and synthetic organic chemistry. Good written, oral communication and computational skills. Always ready to assignment on teaching and/or research.
Done Ph.D. (thesis entitled "Design and Synthesis of Novel Nuclear Receptor Modulator”) in Medicinal Chemistry from Central Drug Research Institute, Lucknow India. she have also three years industrial experience. During the course of  Ph.D program and job at industry, worked on various aspects of Synthetic and Medicinal Chemistry. She has also done post doctorate with Dr. Julio Camarero in university of southern California.

Her research work based on the design, synthesis and biological study of novel scaffolds for the treatment of osteoporosis and breast cancer disease. In order to obtain a new potential lead, our drug discovery effort were focused toward identifying a potential SERMs,  have designed and synthesized several novel synthetic scaffolds and evaluated them for their anti-osteoporotic, anti-implantation and anti-proliferative activity. she explored myself with the interface of Organic Chemistry and Biology.
In this process, She synthesized series of carbocyclic and heterocyclic scaffolds.

After submission of her thesis, she joined pharmaceutical industry and worked on the design and multiple step synthesis of biologically active molecules. There she also worked on to develop new synthetic methods with good yield. During her stay in Industry, she worked on various metal halogen exchange and C-H activation reactions and she developed a huge interest in metal exchange chemistry. Currently she is residing in Pleasanton, CA

Dr. Akanksha Gupta, Ph.D. (Medicinal & Process Chemistry) Mobile+1 (510)-736-9076 (cell)


PG diploma in Intellectual property rights

Indira Gandhi National Open University (IGNOU)
October 2012 – Present (2 years 7 months)Noida

Post Doctoral Reasearch Fellow

University of Southern California
September 2011 – September 2012 (1 year 1 month)California, CA
Research on Peptide chemistry

Research Scientist

Teva Pharmaceutical Industries Ltd.
June 2010 – August 2011 (1 year 3 months)Greater Noida, INDIA
Process development of API and impuritiy profiling: Design syntheitic route, synthesis, characterization and purification of impurities in various APIs like Tadalafil, Valsartan, Pregabalin, Gemfibrozil, Atorvastatin, Derifenacine etc. Identification, quantification, and control of impurities in the active pharmaceutical drug substance. Identification of impurity by various chromatographic as well as spectroscopic methods such as HPLC, UPLC, LCMS, GCMS, NMR, IR and purification by crystallization, Column and combi-flash tequnique

Senior Research Scientist

April 2009 – May 2010 (1 year 2 months)Hyderabad Area, India
Design novel synthetic routes to target molecules, planning and executing projects independently and to demonstrate expertise in both the theoretical and practical aspects of organic chemistry.

Senior Research Associate

May 2008 – April 2009 (1 year)Hyderabad Area, India
Responsible to finish project on time with high quality, communication with client and co-ordination with chemists, preparation of update and final reports. Handled catalogue compounds and also did multi kilo scale project. Prepared 6- 8 kg compound

Research Scholar

Central Drug Research Institute, Lucknow Edit Ph.D, Medicinal Organic Chemistry
August 2003 – May 2008 (4 years 10 months)Lucknow Area, India


Post Doctoral Reasearch Fellow

University of Southern California
September 2011 – September 2012 (1 year 1 month)California, CA
Research on Peptide chemistry

PG diploma in Intellectual property rights

Indira Gandhi National Open University (IGNOU)
October 2012 – Present (2 years 7 months)Noida

Central Drug Research Institute, Lucknow

Ph.D, Medicinal Organic Chemistry
2003 – 2008
Research work focused on design and synthesis of novel scaffolds which act as nuclear receptor modulator and used for the prevention and treatment of various high profile human diseases such as breast cancer, endometrial cancer, osteoporosis, diabetes and in fertility regulation etc. Among the nuclear hormone receptors super gene family we are most interested in estrogen receptor (ER) and also in peroxisome-proliferators-activated receptor for anti-diabetic activity. As estrogen action is also associated with many health problems in women. In order to use estrogen receptor modulator in its full length, we have designed some selective estrogen receptor modulator (SERMs). The aim of the present dissertation is synthesis and identification of some novel scaffolds with selective agonistic as well as antagonistic activity in desired tissue profiles and further the biological evaluation of these scaffolds in vitro cell line model and in vivo animal models for predictive clinical utility.

M.S., Organic Chemistry (2003, 77.3%) Lucknow University, Lucknow (U. P.), India

B.S., Chemistry, Zollogy and Botany (2000,74.4%) Lucknow University, Lucknow, (U. P.), India


· “Amino acid catalyzed thio-Michael addition reactions” Atul Kumar, Akanksha. Tetrahedron, 2007, 63, 11086-11092. 

· “Zirconium chloride catalyzed efficient synthesis of 1, 3-diaryl-2-propenones in solvent free conditions via aldol condensation” Atul Kumar, Akanksha. Journal of Molecular Catalysis A: Chemical, 2007, 274, 212-216. 

· “HbA/H2O2: an efficient biomimetic catalytic system for the oxidation of sulfides to sulfoxides” Atul Kumar, Akanksha. Tetrahedron Letters, 2007, 48, 7857-7860. 

· “An efficient one way selective oxidative cleavage of oximes using hypervalent iodine” Atul Kumar, Pervez Ahmad, Akanksha and Ram Awatar Murya. Combinatorial Chemistry and high throughput screening, 2005, 8, 445-447. 

· “Multicomponent, solvent-free synthesis of β-aryl-β-mercapto ketones using zirconium chloride as a catalyst” Atul Kumar, Akanksha. Tetrahedron Letters, 2007, 48, 8730. 

· “Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents” Atul Kumar, Vishwa Deepak Tripathi, Promod Kumar, Lalit Prakash Gupta, Akanksha, Ritu Trivedi, Hemant Bid, V.L. Nayak, Jawed A. Siddiqui, Bandana Chakravarti, Ruchi Saxena, Anila Dwivedi, M.I. Siddiquee, U. Siddiqui, Rituraj Konwar, Naibedya Chattopadhyay. Bioorganic & Medicinal Chemistry, 2011,19 5409.

 · Design and Synthesis of novel benzisoxazole motif with basic amino anti-estrogenic side chain as ER-receptor subtype ligands selective. Bioorganic and Medicinal Chemistry letter.Atul Kumar, Akanksha Communicated. Attented/Paper Presented in International 

· Attended “Indian Science Congress” from Lucknow University, Lucknow, India, 3-7 January 2002. · Attended the joint International Conference on “Current Trends in Drug Discovery Research” Central Drug Research Institute, Lucknow, India, 17-21 Febuary-2004. · IInd Inter. Symp. on Current Trends in Drug Discovery Research, Central Drug Research Institute, Lucknow, India, 17-22 Febuary-2007. Presented a poster on in the “Qunoline amide as a antithrombotic agent.” · 10th National Symposium in Chemistry, Indian Institute of Science, Bangalore, 1 Febuary-2008. Presented a poster on “Human hemoglobin an efficient biomimetic catalytic system for the oxidation of sulfides to sulfoxides.”

Selected Abstracts · “Qunoline amide as a antithrombotic agent.” Atul Kumar, Akanksha. 2nd Inter. Symp. on Curr.Trends in Drug Discovery Res. (CTDDR-2006),organized by CDRI (CSIR), Lucknow, India, Feb 2006. · “Human hemoglobin an efficient biomimetic catalytic system for the oxidation of sulfides to sulfoxides.” Atul Kumar, Akanksha.10th National Symposium in Chemistry Division of Chemical Sciences organized by Indian Institute of Science, Bangalore.

Selected Oral presentation · “Artificial Sweetners” (Jan 2003) in University of Lucknow, Lucknow · “Design and Synthesis of Novel Nuclear Receptor Modulator” (Jan 2008) at Central Drug Research Institute, Lucknow-226001, India. · Diels Alder Reaction” (April 2006) at Central Drug Research Institute, Lucknow-226001, India.
  1. Map of pleasanton california
The Altamont Commuter Express train leaving Pleasanton station in the afternoon

Muirwood Park, Pleasanton